[1]寇志军,李 静,马亨曼,等.川崎病患儿心血管病变易感性与血清N末端B型脑钠肽原、前白蛋白及C-反应蛋白表达水平相关性研究[J].陕西医学杂志,2022,51(6):717-720.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
　KOU Zhijun,LI Jing,MA Hengman,et al.Correlation between cardiovascular disease susceptibility and serum levels of NT-proBNP,PA and CRP in children with Kawasaki disease[J].,2022,51(6):717-720.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.018]
点击复制

川崎病患儿心血管病变易感性与血清N末端B型脑钠肽原、前白蛋白及C-反应蛋白表达水平相关性研究
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
51
期数:
2022年6期
页码:
717-720
栏目:
临床研究
出版日期:
2022-06-05

文章信息/Info

Title:
Correlation between cardiovascular disease susceptibility and serum levels of NT-proBNP,PA and CRP in children with Kawasaki disease
作者:
寇志军1; 3; 李 静2; 马亨曼3; 全守东3
(1.锦州医科大学,辽宁 锦州 121001; 2.锦州医科大学附属第一医院,辽宁 锦州 121004; 3.朝阳市第二医院,辽宁 朝阳 122099)
Author(s):
KOU Zhijun; LI Jing; MA Hengman; QUAN Shoudong
(Jinzhou Medical University,Jingzhou 121001,China)
关键词:
川崎病;  心血管病变易感性;  N末端B型脑钠肽原;  前白蛋白;  C-反应蛋白;  相关性
Keywords:
Kawasaki disease;  Cardiovascular disease susceptibility;  N-terminal B-type natriuretic peptide;  Prealbumin;  C-reactive protein;  Correlation
分类号:
R 725.4
DOI:
DOI:10.3969/j.issn.1000-7377.2022.06.018
文献标志码:
A
摘要:
目的:探究川崎病患儿心血管病变易感性与血清N末端B型脑钠肽原(NT-proBNP)、前白蛋白(PA)及C-反应蛋白(CRP)水平的相关性。方法:回顾性分析92例川崎病患儿的临床资料,依据是否出现心血管病变分为A组(49例,发生心血管病变)和B组(43例,未发生心血管病变)。另选取同期体检健康儿童40例作为对照组。比较三组血清NT-proBNP、PA、CRP水平。采用Pearson法分析川崎病患儿心血管病变与血清NT-proBNP、PA、CRP水平的相关性。采用Logistic回归模型分析川崎病患儿发生心血管病变的危险因素。结果:三组血清NT-proBNP、PA、CRP水平组间比较差异有统计学意义(P<0.05)。A组和B组血清NT-proBNP、CRP水平高于对照组,且A组高于B组(均P<0.05)。A组和B组血清PA水平低于对照组,且A组低于B组(均P<0.05)。Pearson相关性分析表明,川崎病患儿心血管病变与血清NT-proBNP、CRP水平呈正相关,与血清PA水平呈负相关(r=0.463、0.356、-0.391,均 P<0.05)。Logistic回归分析结果显示,血清NT-proBNP、PA水平是川崎病患儿发生心血管病变的独立危险因素(均P<0.05)。结论:川崎病患儿心血管病变易感性与血清NT-proBNP、PA及CRP水平有关。血清NT-proBNP、CRP水平上升与PA水平下降预示着川崎病患儿心血管病变易感性提升。可以将NT-proBNP及PA水平作为预测川崎病患儿是否发生心血管病变的血清学指标。
Abstract:
Objective:To explore the correlation between cardiovascular disease susceptibility and serum levels of N-terminal B-type natriuretic peptide(NT-proBNP),prealbumin(PA)and C-reactive protein(CRP)in children with Kawasaki disease.Methods: The clinical data of 92 children with Kawasaki disease were retrospectively analyzed.They were divided into group A(49 cases with cardiovascular disease)and group B(43 cases without cardiovascular disease)according to the presence or absence of cardiovascular disease.Another 40 healthy children were selected as control group.Serum levels of NT-proBNP,PA and CRP were compared among the three groups.Pearson correlation analysis was used to analyze the correlation between cardiovascular disease and serum levels of NT-proBNP,PA and CRP in children with Kawasaki disease.Logistic regression model was used to analyze the risk factors of cardiovascular disease in children with Kawasaki disease.Results:There were significant differences in serum NT-proBNP,PA and CRP levels among the three groups(P<0.05).The levels of serum NT-proBNP and CRP in group A and group B were higher than those in control group,and those in group A were higher than those in group B(all P<0.05).Serum PA level in group A and group B was lower than that in control group,and that in group A was lower than that in group B(all P<0.05).Pearson correlation analysis showed that cardiovascular disease in children with Kawasaki disease was positively correlated with serum NT-proBNP and CRP levels,and negatively correlated with serum PA levels(r=0.463,0.356,-0.391,all P<0.05).Logistic regression analysis showed that serum NT-proBNP and PA levels were independent risk factors for cardiovascular disease in children with Kawasaki disease(all P<0.05).Conclusion:Cardiovascular disease susceptibility in children with Kawasaki disease is related to serum NT-proBNP,PA and CRP levels.Elevated serum NT-proBNP and CRP levels and decreased PA level indicate increased cardiovascular disease susceptibility in children with Kawasaki disease.NT-proBNP and PA levels can be used as serological indicators to predict the development of cardiovascular disease in children with Kawasaki disease.

参考文献/References:

[1] 杨荣荣,马佳娜.超声心动图和心肌酶学检测在患儿川崎病合并冠状动脉病变诊断中的应用[J].陕西医学杂志,2020,49(10):1259-1261,1265.
[2] Fan L,Lv H,Jiang S,et al.Low-dose prednisone treatment for IVIG-resistant Kawasaki disease with severe arthritis and joint effusion in two 3-year-old children[J].Case Reports in Pediatrics,2021,2021:6618346.
[3] 赖雪芹,赵 青,郭健秋,等.N端前脑钠肽与原田危险评分、小林评分对川崎病病儿冠状动脉病变风险预测价值的对比[J].安徽医药,2020,24(4):688-691.
[4] Fukazawa R,Kobayashi J,Ayusawa M,et al.JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J].Circ J,2020,84(8):1348-1407.
[5] 陈婷婷,杨艳峰,柳颐龄,等.影像学检查与心导管术在川崎病心血管后遗症诊断、治疗及长期管理中的应用进展[J].中华实用儿科临床杂志,2021,36(8):561-565.
[6] 李建泳,吴雅娟.川崎病合并冠状动脉损害的研究进展[J].中国心血管杂志,2021,26(6):597-600.
[7] 中华医学会儿科学分会心血管学组,中华儿科杂志编辑委员会.川崎病冠状动脉病变的临床处理建议(2020年修订版)[J].中华儿科杂志,2020,58(9):718-724.
[8] 谭朝中,刘 芳.川崎病严重冠状动脉病变的治疗和长期管理[J].中国小儿急救医学,2020,27(9):661-665.
[9] 谢利剑,黄 敏.川崎病诊断预测模型的研究进展[J].中国小儿急救医学,2021,28(12):1103-1106.
[10] 任红杰,赵安社,安谊沛,等.芪苈强心胶囊联合西药治疗慢性心力衰竭疗效及对患者NT-proBNP、hs-CRP、VEGF的影响[J].陕西中医,2019,40(6):711-713.
[11] 赵 将.川崎病患儿血清前白蛋白血红素加氧酶-1及炎性指标对冠状动脉病变的预测价值研究[J].中国药物与临床,2021,21(16):2866-2868.
[12] 赵 玮.血清白蛋白、CRP及GDF-15与川崎病患儿冠脉损伤的相关性[J].内蒙古医科大学学报,2020,42(3):296-299.
[13] 林 瑶,李晓惠,石 琳,等.2017年版《川崎病的诊断、治疗及远期管理——美国心脏协会对医疗专业人员的科学声明》解读[J].中国实用儿科杂志,2017,32(9):641-648.
[14] 王程浩,刘 芳.川崎病所致冠状动脉病变的病理改变及结局[J].中华实用儿科临床杂志,2021,36(22):1757-1760.
[15] 孙春晖,乐 原.川崎病合并冠状动脉病变患儿前白蛋白、胱抑素C、血小板四项变化及临床意义[J].陕西医学杂志,2021,50(12):1573-1576.
[16] 于晓晴,张乾忠,祝 华.川崎病并发冠状动脉损害的诊治进展[J].中国小儿急救医学,2021,28(12):1107-1110.
[17] 刘晓燕,王曼知,陈 芳,等.对氧磷酶1基因Q192R和L55M位点多态性与川崎病冠状动脉损伤的相关性[J].中华实用诊断与治疗杂志,2020,34(5):470-473.
[18] 谢丽萍,刘 芳.冠状动脉搭桥术在川崎病合并严重冠状动脉病变中的应用进展[J].中华儿科杂志,2020,58(3):252-255.
[19] 刘武辉,林友青,骆晓文.川崎病患儿NLR、PLR、SII、ESR水平变化及临床意义[J].海南医学,2021,32(13):1698-1701.
[20] 吴业媚,徐明国.外周血细胞参数对川崎病临床预测作用的研究进展[J].中华实用儿科临床杂志,2020,35(13):1027-1030.
[21] 骆 盼,李金玲,柳成良.CT、超声心动图在小儿川崎病冠状动脉病变患者心功能评估中的价值对比[J].中国CT和MRI杂志,2022,20(1):85-87.
[22] 于 斌,陈 华,秦 皓,等.血cTnI、NT-proBNP水平对脓毒症心肌损伤患者28 d存活率的预测价值[J].河北医药,2020,42(24):3708-3712.
[23] 叶 婷,罗雪清,黄美金,等.糖尿病合并肺结核患者前白蛋白、视黄醇结合蛋白水平及其与营养状况的相关性研究[J].广西医学,2020,42(2):160-163.
[24] 沈志远,张 林.C-反应蛋白的构象变化和动脉粥样硬化关系的研究进展[J].生命科学研究,2020,24(6):504-510.
[25] 杜明丽,李桂香,赵 磊,等.血清C反应蛋白、前白蛋白及其比值在胃癌中的研究进展[J].华西医学,2021,36(3):401-405.

相似文献/References:

[1]孙春晖,乐 原.川崎病合并冠状动脉病变患儿前白蛋白、胱抑素C、血小板四项变化及临床意义[J].陕西医学杂志,2021,50(12):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
　SUN Chunhui,LE Yuan.Changes and clinical significance of prealbumin,cystatin C and four parameters of platelet in Kawasaki disease children with coronary arterial lesions[J].,2021,50(6):1573.[doi:DOI:10.3969/j.issn.1000-7377.2021.12.027]
[2]严晓华,王 娜,马 娟,等.阿托伐他汀对小鼠川崎病的治疗作用及机制研究[J].陕西医学杂志,2022,51(6):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
　YAN Xiaohua,WANG Na,MA Juan,et al.Therapeutic effect and mechanism of atorvastatin on Kawasaki disease mice[J].,2022,51(6):672.[doi:DOI:10.3969/j.issn.1000-7377.2022.06.007]
[3]赵 萌,杨轶童,李翰文,等.肠道微生物菌群与川崎病关系研究进展[J].陕西医学杂志,2024,(2):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
　ZHAO Meng,YANG Yitong,LI Hanwen,et al.Research progress on relationship between gut microbiota and Kawasaki disease[J].,2024,(6):270.[doi:DOI:10.3969/j.issn.1000-7377.2024.02.027]
[4]杨 敏,刘 鑫.血清可溶性肿瘤坏死因子受体Ⅱ/Ⅰ比值、白细胞介素-17联合心电图诊断川崎病患儿急性期冠状动脉损伤的价值[J].陕西医学杂志,2025,54(3):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]
　YANG Min,LIU Xin.Value of serum sTNFR Ⅱ/Ⅰ,IL-17 combined with ECG in diagnosis of coronary artery injury in children with Kawasaki disease in acute phase[J].,2025,54(6):338.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.010]
[5]冯千伟,王晓青,焦丽华,等.川崎病患儿血清血管生成素样蛋白8、生长分化因子-15水平与并发冠状动脉病变关系研究[J].陕西医学杂志,2025,54(3):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]
　FENG Qianwei,WANG Xiaoqing,JIAO Lihua,et al.Relationship between serum ANGPTL8,GDF-15 levels with concurrent coronary artery disease in children with Kawasaki disease[J].,2025,54(6):364.[doi:DOI:10.3969/j.issn.1000-7377.2025.03.015]

备注/Memo

备注/Memo:
基金项目:辽宁省自然科学基金指导计划项目(20180551155)
更新日期/Last Update: 2022-06-06